Alcide Corporation Announces Approval for Sale of Sanova in Canada.REDMOND, Wash.--(BW HealthWire)--Oct. 1, 1999-- Alcide Corporation (Nasdaq:ALCD ALCD Association of Law Costs Draftsmen ALCD Analogue Libraries on Low-Cost CMOS Digital Process (ESPRIT Project 8030) ) today announced that it has received approval for use of its Sanova antimicrobial in Canada for the purpose of reducing pathogens such as E. coli E. coli: see Escherichia coli. E. coli in full Escherichia coli Species of bacterium that inhabits the stomach and intestines. E. coli can be transmitted by water, milk, food, or flies and other insects. , Salmonella, Campylobacter Campylobacter Genus of gram-negative spiral-shaped bacteria infecting mammals. Many species, especially C. fetus, cause miscarriage in sheep and cattle. C. jejuni is a common cause of food poisoning. Sources include meats (particularly chicken) and unpasteurized milk. and Listeria Listeria /Lis·te·ria/ (lis-ter´e-ah) a genus of gram-negative bacteria (family Corynebacterium); L. monocyto´genes causes listeriosis. Lis·te·ri·a n. on poultry carcasses. With this approval Sanova may now be sold to processing plants in Canada and may be used in U.S. plants on poultry exported to Canada. Alcide Corporation develops and markets unique biocidal bi·o·cid·al adj. Of or relating to an agent that is destructive to living organisms. biocidal (bī´ōsī´d products based on its patented technology. Alcide currently sells anti-infective products to the animal health market, disinfecting products to the medical industries, and an antimicrobial for controlling food borne pathogens on poultry. The Company intends to broaden its business base through further regulatory approval and market introduction of the same antimicrobial for controlling food borne pathogens in other areas. This earnings report includes forward looking statements which involve risk and uncertainty including, without limitation, risk of dependence on third party suppliers, market acceptance of and demand for the Company's products, distribution capabilities, and development of technology and regulatory approval thereof. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion